Aging Well with HIV: Strategies to Mitigate Cardiovascular Risk in Older Adults
This two-module activity addresses the current state of HIV in the US and healthy aging considerations for persons living with HIV (PLWH). Also included are brief vignettes of actual patient interviews. Their perspectives will provide insight into the daily challenges and quality of life issues that can occur while living with HIV.
Our experts discuss the changes in care due to the advent of highly active antiretroviral therapy (HAART). Life expectancies for PLWH are now similar to those for uninfected people. A growing proportion of HIV-infected individuals are now over the age of 50, and we are also seeing an increase in the incidence of HIV infection in older adults. To meet the challenges of the ongoing HIV epidemic, HIV care providers must now address the many comorbidities that are common in the aging population.
Cardiovascular diseases (CVD) are among the most prevalent non-communicable comorbidities in PLWH, and gaps in optimal CV risk factor management in this population is illustrative of the need to emphasize an aging-centric approach to the care of older PLWH. From a cardiovascular standpoint, routine risk screening for cardiovascular health maintenance metrics is sub-optimal, which can result in under-identification and/or under-treatment. Additionally, older adults living with HIV infection may be doubly stigmatized, as they are branded by both age as well as HIV status.3 And with any chronic disease, adherence remains a significant problem in HIV as well.
The growing number of PLWH over age 50 requires research, to develop a more comprehensive understanding of the health consequences of HIV in older individuals. The intent of this CME program is to help clinicians improve the health of older PLWH.
Infectious disease specialists, geriatricians, primary care and internal medicine physicians, pharmacists, NP/PAs, and nurses
After completing this activity, participants should be able to:
1. Evaluate age-related considerations for treating HIV to promote better health in the aging population.
2. Review the relationship between HIV and cardiovascular disease along with how to manage them together in practice.
3. Identify factors that hinder medication adherence in PLWH and ways to overcome these barriers.
4. Utilizing video vignettes of actual patients, identify opportunities for improving health-related quality of life among older patients living with HIV from a multidimensional care lens.
5. Recognize forward-thinking strategies clinicians can employ to optimize treatment and positive health outcomes for their patients with HIV while mitigating the risk of infection from COVID-19.
This program is supported by an educational grant from Gilead Sciences, Inc.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours 2.5, of which 1 are eligible for pharmacology credit (if applicable)
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This is an application-based educational activity. Pharmacists will receive 2.5 contact hours (0.25 CEUS) for the educational activity. No partial credit is available. Initial Release Date: August 1, 2021. Planned Expiration Date: August 1, 2022.
Universal Activity Number (UAN): 0060-9999-21-021-H01-P
- 2.50 ACPE Pharmacy
- 2.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.50 ANCCBoston University Chobanian & Avedisian School of Medicine, Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.